Other Income & Expense
Interest Expense
Revolution Medicines, Inc. Interest Expense increased by 6.7% to $12.20M in Q1 2026 compared to the prior quarter. Over 2 years (FY 2021 to FY 2023), Interest Expense shows a downward trend with a -100.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryLeverage
SignalLower is better
VolatilityStable
First reportedQ1 2023
Last reportedQ1 2026
How to read this metric
Increasing interest expense may signal higher debt levels or rising interest rates, which can reduce net profitability.
Detailed definition
Interest expense represents the cost incurred by a company for borrowed funds, such as loans, bonds, or other debt instr...
Peer comparison
Highly dependent on the company's capital structure; peers with lower debt-to-equity ratios will show lower interest expenses.
Metric ID:
interest_expenseHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q1 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $11.43M | $12.20M |
| QoQ Change | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +6.7% |
Range$0.00 – $12.20M
Interest Expense at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s interest expense?
- Revolution Medicines, Inc. (RVMD) reported interest expense of $12.20M in Q1 2026.
- What is the long-term trend for Revolution Medicines, Inc.'s interest expense?
- Over 2 years (2021 to 2023), Revolution Medicines, Inc.'s interest expense has grown at a -100.0% compound annual growth rate (CAGR), from $12.00K to $0.00.
- What does interest expense mean?
- The cost of borrowing money, paid as interest on debt.